4//SEC Filing
ZASLOFF MICHAEL A 4
Accession 0001415889-24-007093
CIK 0001297184other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 5:57 PM ET
Size
6.7 KB
Accession
0001415889-24-007093
Insider Transaction Report
Form 4
ZASLOFF MICHAEL A
Director
Transactions
- Sale
Common Stock
2024-03-05$47.06/sh−9,389$441,871→ 24,437 total - Sale
Common Stock
2024-03-05$47.53/sh−3,111$147,853→ 21,326 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.435 to $47.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.435 to $47.68, inclusive.
Documents
Issuer
Amphastar Pharmaceuticals, Inc.
CIK 0001297184
Entity typeother
IncorporatedPA
Related Parties
1- filerCIK 0001033511
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 5:57 PM ET
- Size
- 6.7 KB